Carrier testing
- The purpose of CF carrier testing is for couples to identify if they are both carriers and therefore have a
1 in 4 chance of having a baby with CF. In this situation, it is important that carrier testing be performed
prior to pregnancy, where possible. - If a couple know they are both carriers prior to pregnancy, they are able to consider reproductive options,
such as having prenatal diagnosis or pre-implantation genetic diagnosis, or to prepare themselves and their obstetric team for the possibility of having a child with CF (see Testing and pregnancy). - Routine carrier testing detects the most common mutations. The panel of mutations that are commonly
screened for varies amongst the Australian States/Territories. See Contacts, support and testing for
contact details. - The frequency of particular mutations varies between populations; therefore, knowledge of ethnicity assists carrier testing.
- Results are usually available in three to four weeks.
Who should be offered carrier testing?
- All 1° relatives of an individual with CF and, if positive, other relatives (see Table 1 for risk of being a carrier).
- Partners of individuals with CF.
- Partners of carriers for a CFTR mutation.
- Couples in close consanguineous relationships, particularly in ethnic groups where the CF carrier rate is high (eg Northern European, Ashkenazi Jewish).
- Men who are infertile due to, or suspected to be due to CBAVD, and their partners if they are planning a family.
Carrier testing in the general population
- CF carrier screening is now available in all states in Australia even where there is no family history of CF.
- There is currently no Medicare rebate available and there are out-of-pocket costs for the tests, which may be performed by a self-administered cheek brush test.
- Information regarding CF screening is available from Genetics Services.


